1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cysteine in 9 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 40,132 | 418 | 11,457 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dembińska-Kieć, A; Peskar, BA; Peskar, BM | 1 |
| Benveniste, J; Hadji, L; Mencia-Huerta, JM | 1 |
| Le Gouill, C; Parent, JL; Rola-Pleszczynski, M; Stanková, J | 1 |
| Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH; Snouwaert, JN | 1 |
| Grimminger, F; Kiss, L; Mayer, K; Seeger, W; Walmrath, D | 1 |
| Bizer, C; Schapowal, A; Simon, HU; Thomet, OA; Wiesmann, UN | 1 |
| Blaser, K; Simon, HU; Thomet, OA; Wiesmann, UN | 1 |
| Kolaczkowska, E; Plytycz, B; Seljelid, R; Shahzidi, S; van Rooijen, N | 1 |
| Baccei, CS; Bain, G; Broadhead, AR; Chapman, C; Correa, LD; Darlington, JV; Evans, JF; Hutchinson, JH; King, CD; Lee, C; Lorrain, DS; Prasit, P; Prodanovich, PP; Roppe, J; Santini, AM; Stearns, B; Stock, NS; Zunic, J | 1 |
9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cysteine
| Article | Year |
|---|---|
Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
Topics: Animals; Chromones; Cysteine; Diterpenes; Ginkgolides; Indomethacin; Lactones; Leukotrienes; Male; Masoprocol; Platelet Activating Factor; Rats; Rats, Inbred Strains; Splanchnic Circulation; SRS-A; Stomach | 1988 |
Release of a slow-reacting substance from rabbit platelets.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Autacoids; Blood Platelets; Chromatography, High Pressure Liquid; Cysteine; Indomethacin; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1981 |
Role of the Cys90, Cys95 and Cys173 residues in the structure and function of the human platelet-activating factor receptor.
Topics: Amino Acid Sequence; Animals; Azepines; Binding, Competitive; CHO Cells; COS Cells; Cricetinae; Cysteine; Dithiothreitol; DNA Primers; Humans; Inositol Phosphates; Kinetics; Models, Structural; Mutagenesis, Site-Directed; Platelet Activating Factor; Platelet Membrane Glycoproteins; Polymerase Chain Reaction; Protein Structure, Secondary; Proto-Oncogene Proteins c-myc; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Transfection; Triazoles | 1997 |
Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Topics: Acute Disease; Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Movement; Crosses, Genetic; Cysteine; Dermatitis, Contact; Ear; Epoxide Hydrolases; Fluorescein-5-isothiocyanate; Immunoglobulin E; Inflammation Mediators; Leukotriene B4; Leukotrienes; Lipopolysaccharides; Mice; Mice, Knockout; Neutrophils; Peritonitis; Platelet Activating Factor | 1999 |
PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Capillaries; Cysteine; Drug Combinations; Eicosapentaenoic Acid; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotrienes; Lung; Neutrophils; Platelet Activating Factor; Pulmonary Circulation; Rabbits | 2000 |
Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asteraceae; Calcium; Complement C5a; Cysteine; Eosinophils; Humans; Hydroxyurea; In Vitro Techniques; Leukotriene B4; Leukotrienes; Macrophages; Neutrophils; Plant Extracts; Platelet Activating Factor; Sesquiterpenes; Signal Transduction | 2001 |
Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.
Topics: Active Transport, Cell Nucleus; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Calcium; Cell Nucleus; Cells, Cultured; Complement C5a; Cysteine; Cytoplasm; Enzyme Inhibitors; Eosinophil Granule Proteins; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Ribonucleases; Sesquiterpenes | 2001 |
Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Leak Syndrome; Capillary Permeability; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cysteine; Diterpenes; Eicosanoids; Enzyme Induction; Ginkgolides; Histamine Release; Indoles; Indomethacin; Isoenzymes; Lactones; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Mast Cells; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Nitrobenzenes; Peritonitis; Phospholipid Ethers; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Quinolines; Sulfonamides; Thioglycolates; Zymosan | 2002 |
Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Carrier Proteins; Chronic Disease; Cysteine; Disease Models, Animal; Female; Humans; Indoles; Inflammation; Leukotriene B4; Leukotrienes; Lung; Male; Membrane Proteins; Mice; Pentanoic Acids; Platelet Activating Factor; Propionates; Rats; Substrate Specificity; Zymosan | 2010 |